中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2018年·北京)[J].中国实用内科杂志,2018,38(9):796-813.

NG SC,SHI HY,HAMIDI N,et al.Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century:a systematic review of population-based studies[J].Lancet,2017,390(10114):2769-2778.

ORDÁS I,ECKMANN L,TALAMINI M,et al.Ulcerative colitis[J].Lancet,2012,380(9853):1606-1619.

赵鲁卿,王典朋,孙梦云,等.溃疡性结肠炎活动期大肠湿热证临床特点及其与血栓形成预测指标的相关性分析[J].中华中医药杂志,2021,36(7):4258-4261.

张声生,赵鲁卿.溃疡性结肠炎的中医治疗策略和思考[J].中国中西医结合消化杂志,2016,24(6):411-413.

赵鲁卿,吴茜,张声生.张声生教授以“寒热”为纲辨治溃疡性结肠炎的思路和治疗策略[J].中国中西医结合消化杂志,2021,29(2):141-143.

RUBIN DT,ANANTHAKRISHNAN AN,SIEGEL CA,et al.ACG clinical guideline: Ulcerative colitis in adults[J].Am J Gastroenterol,2019,114(3):384-413.

UNGARO R,COLOMBEL JF,LISSOOS T,et al.A treat-to-target update in ulcerative colitis: a systematic review[J].Am J Gastroenterol,2019,114(6):874-883.

MAGRO F,DOHERTY G,PEYRIN-BIROULET L,et al.ECCO position paper:harmonization of the approach to ulcerative colitis histopathology[J].J Crohns Colitis,2020,14(11):1503-1511.

戴小玲,林江.溃疡性结肠炎的治疗目标：组织学缓解[J].中华炎性肠病杂志,2021,5(3):233-236.

SHEN H,ZHANG S,ZHAO W,et al.Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis[J].Biomed Pharmacother,2021,139:111580.

沈洪,张声生,王垂杰,等.中药分期序贯治疗轻中度溃疡性结肠炎111例疗效观察[J].中医杂志,2011,52(13):1108-1111.

沈洪,张声生,王垂杰,等.中药分期序贯治疗轻中度溃疡性结肠炎临床观察[J].中华中医药杂志,2012,27(7):1788-1791.

张声生,杨雪,赵鲁卿,等.清热除湿中药灌肠方治疗溃疡性结肠炎近期疗效的观察[J].中国中西医结合消化杂志,2017,25(6):401-405.

王海林,陈敏,侯波,等.痛泻要方联合电针治疗肝脾不和型溃疡性结肠炎临床研究[J].四川中医,2020,38(7):124-127.

YOON H,JANGI S,DULAI PS,et al.Incremental benefit of achieving endoscopic and histologic remission in patients with ulcerative colitis: a systematic review and meta-analysis[J].Gastroenterology,2020,159(4):1262-1275.e7.

NAGANUMA M,SUGIMOTO S,MITSUYAMA K,et al.Efficacy of indigo naturalis in a multicenter randomized controlled trial of patients with ulcerative colitis[J].Gastroenterology,2018,154(4):935-947.

闻永,石蕾,李俊,等.针刺联合穴位埋线序贯治疗轻中度溃疡性结肠炎[J].中国针灸,2018,38(4):353-357.

王志斌,陈晨,郭一,等.清肠温中方治疗轻中度溃疡性结肠炎的临床研究[J].中国中西医结合杂志,2018,38(1):15-19.

陈洁玲,沈杰,刘国正.“益气解毒化瘀方”联合常规西药治疗溃疡性结肠炎30例临床研究[J].江苏中医药,2021,53(3):34-37.

SANDS BE,SANDBORN WJ,PANACCIONE R,et al.Ustekinumab as induction and maintenance therapy for ulcerative colitis[J].N Engl J Med,2019,381(13):1201-1214.

绳荣湍,陈良荣,方健松,等.从结肠黏膜超微结构变化及Claudin⁃2、5表达探讨健脾清热活血方干预溃疡性结肠炎的临床研究[J].中国中西医结合消化杂志,2020,28(9):688-692.

王倬,陈强,孔斌,等.葛根芩连裁减方结合益生菌对溃疡性结肠炎血清IL⁃6、IL⁃12、IL⁃10和TGF⁃β水平的影响[J].中华中医药学刊,2022,40(3):248-251.

张天彬.健脾活血解毒颗粒联合美沙拉嗪肠溶片治疗虚实夹杂证轻度活动期溃疡性结肠炎的临床观察[D].南宁：广西中医药大学，2020.

UNGARO R,MEHANDRU S,ALLEN PB,et al.Ulcerative colitis[J].Lancet,2017,389(10080):1756-1770.

COHEN RD,YU AP,WU EQ,et al.Systematic review: the costs of ulcerative colitis in western countries[J].Aliment Pharmacol Ther,2010,31(7):693-707.

SADEGHI N,MANSOORI A,SHAYESTEH A,et al.The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis[J].Phytother Res,2020,34(5):1123-1133.

QI Q,IM H,LI KS,et al.Influence of herb-partitioned moxibustion at Qihai(CV6)and bilateral Tianshu(ST25)and Shangjuxu(ST37)acupoints on toll-like receptors 4 signaling pathways in patients with ulcerative coliti[J].J Tradit Chin Med,2021,41(3):479-485.

DAI YC,ZHENG L,ZHANG YL,et al.Effects of Jianpi Qingchang decoction on the quality of life of patients with ulcerative colitis: A randomized controlled trial[J].Medicine(Baltimore),2017,96(16):e6651.

HANAI H,IIDA T,TAKEUCHI K,et al.Curcumin maintenance therapy for ulcerative colitis:randomized, multicenter,double-blind,placebo-controlled trial[J].Clin Gastroenterol Hepatol,2006,4(12):1502-1506.

丛龙玲,姚嘉茵,吴宇金,等.肠炎清合剂联合美沙拉嗪肠溶片维持治疗缓解期溃疡性结肠炎的临床疗效[J].中国实验方剂学杂志,2021,27(3):99-104.

GUO XY,LIU XJ,HAO JY.Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment[J].J Dig Dis,2020,21(3):147-159.

MARTINI E,KRUG SM,SIEGMUND B,et al.Mend your fences:the epithelial barrier and its relationship with mucosal immunity in inflammatory bowel disease[J].Cell Mol Gastroenterol Hepatol,2017,4(1):33-46.

ZHAO L,ZHANG S,HE P.Mechanistic understanding of herbal therapy in inflammatory bowel disease[J].Curr Pharm Des,2017,23(34):5173-5179.

ZHU R,MA XC.Role of metabolic changes of mucosal layer in the intestinal barrier dysfunction following trauma/hemorrhagic shock[J].Pathol Res Pract,2018,214(11):1879-1884.

PETERSON LW,ARTIS D.Intestinal epithelial cells: regulators of barrier function and immune homeostasis[J].Nat Rev Immunol,2014,14(3):141-153.

GüNTHER C,NEUMANN H,NEURATH MF,et al.Apoptosis, necrosis and necroptosis: cell death regulation in the intestinal epithelium[J].Gut,2013,62(7):1062-1071.

MO X,TANG K,DENG L,et al.Prevention of ulcerative colitis by Huangqin decoction:reducing the intestinal epithelial cell apoptosis rate through the IFN⁃γ/JAK/ETS signalling pathway[J].Pharm Biol,2022,60(1):1116-1125.

李玉欣,赵鲁卿,张声生,等.清热化湿祛瘀方对溃疡性结肠炎小鼠结肠黏膜氧化应激和细胞凋亡的影响[J].中华中医药杂志,2021,36(3):1727-1730.

WANG Y,LIU J,HUANG Z,et al.Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response[J].Eur J Pharmacol,2021,896:173912.

WEI YY,FAN YM,GA Y,et al.Shaoyao decoction attenuates DSS-induced ulcerative colitis, macrophage and NLRP3 inflammasome activation through the MKP1/NF⁃κB pathway[J].Phytomedicine,2021,92:153743.

HAO Y,NAGASE K,HORI K,et al.Xilei san ameliorates experimental colitis in rats by selectively degrading proinflammatory mediators and promoting mucosal repair[J].Evid Based Complement Alternat Med,2014:569587.

HEINEMANN U,SCHUETZ A.Structural features of tight-junction proteins[J].Int J Mol Sci,2019,20(23)：6020.

WU H,CHEN QY,WANG WZ,et al.Compound sophorae decoction enhances intestinal barrier function of dextran sodium sulfate induced colitis via regulating notch signaling pathway in mice[J].Biomed Pharmacother,2021,133:110937.

WU X,CHEN H,GAO X,et al.Natural herbal remedy Wumei Decoction ameliorates intestinal mucosal inflammation by inhibiting Th1/Th17 cell differentiation and maintaining microbial homeostasis[J].Inflamm Bowel Dis,2022,28(7):1061-1071.

WU Z,ZENG H,ZHANG L,et al.Patchouli alcohol: a natural sesquiterpene against both inflammation and intestinal barrier damage of ulcerative colitis[J].Inflammation,2020,43(4):1423-1435.

BIRCHENOUGH GM,JOHANSSON ME,GUSTAFSSON JK,et al.New developments in goblet cell mucus secretion and function[J].Mucosal Immunol,2015,8(4):712-719.

FISCHER H,STENLING R,RUBIO C,et al.Differential expression of aquaporin 8 in human colonic epithelial cells and colorectal tumors[J].BMC Physiol,2001,1:1.

丁庞华,史利卿,石磊,等.虎地肠溶胶囊对葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠黏液屏障损伤修复的作用研究[J].中国中医急症,2021,30(8):1336-1339,1381.

李姿慧,王键,蔡荣林,等.参苓白术散对脾虚湿困型溃疡性结肠炎大鼠结肠组织AQP4蛋白及mRNA表达的影响[J].世界华人消化杂志,2014,22(12):1688-1693.

KAMADA N,SEO SU,CHEN GY,et al.Role of the gut microbiota in immunity and inflammatory disease[J].Nat Rev Immunol,2013,13(5):321-335.

常为伟,姚宏健,潘慧,等.消溃方灌肠治疗溃疡性结肠炎临床研究及对肠道菌群的影响[J].新中医,2021,53(23):111-116.

ZHAO L,DU X,TIAN J,et al.Berberine-loaded carboxylmethyl chitosan nanoparticles ameliorate dss-induced colitis and remodel gut microbiota in mice[J].Front Pharmacol,2021,12:644387.

LI Q,CUI Y,XU B,et al.Main active components of Jiawei Gegen Qinlian decoction protects against ulcerative colitis under different dietary environments in a gut microbiota-dependent manner[J].Pharmacol Res,2021,170:105694.

ABRAHAM C,MEDZHITOV R.Interactions between the host innate immune system and microbes in inflammatory bowel disease[J].Gastroenterology,2011,140(6):1729-1737.

GEREMIA A,BIANCHERI P,ALLAN P,et al. Innate and adaptive immunity in inflammatory bowel disease[J].Autoimmun Rev,2014,13(1):3-10.

CHIN AC,PARKOS CA.Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking[J].Ann N Y Acad Sci,2006,1072:276-287.

LARMONIER CB,MIDURA-KIELA MT,RAMALINGAM R,et al.Modulation of neutrophil motility by curcumin: implications for inflammatory bowel disease[J].Inflamm Bowel Dis,2011,17(2):503-515.

ZHANG W,XU L,CHO SY,et al.Ginseng berry extract attenuates dextran sodium sulfate-induced acute and chronic colitis[J].Nutrients,2016,8(4):199.

ZHUANG H,LV Q,ZHONG C,et al.Tiliroside ameliorates ulcerative colitis by restoring the M1/M2 macrophage balance via the HIF⁃1α/glycolysis pathway[J].Front Immunol,2021,12:649463.

ZHONG Y,LIU W,XIONG Y,et al.Astragaloside Ⅳ alleviates ulcerative colitis by regulating the balance of Th17/Treg cells[J].Phytomedicine,2022,104:154287.

NEURATH MF.Cytokines in inflammatory bowel disease[J].Nat Rev Immunol,2014,14(5):329-342.

LIU B,PIAO X,NIU W,et al.Kuijieyuan decoction improved intestinal barrier injury of ulcerative colitis by affecting TLR4⁃dependent PI3K/AKT/NF⁃κB oxidative and inflammatory signaling and gut microbiota[J].Front Pharmacol,2020,11:1036.

YANG QY,MA LL,ZHANG C,et al.Exploring the mechanism of indigo naturalis in the treatment of ulcerative colitis based on TLR4/MyD88/NF⁃κB signaling pathway and gut microbiota[J].Front Pharmacol,2021,12:674416.

陈天杰,张明红.参苓白术散治疗慢性复发型溃疡性结肠炎的疗效及基于β2AR/β⁃arrestin2/NF⁃κB信号转导通路的作用机制[J].中药材,2020,43(4):996-999.

张镖,宋雨鸿,周晓芸,等.别旁茶苷通过PXR/NF⁃κB信号通路治疗小鼠溃疡性结肠炎机制研究[J].中药新药与临床药理,2019,30(5):547-552.